DI VITO, CLARA
 Distribuzione geografica
Continente #
NA - Nord America 4.332
AS - Asia 3.959
EU - Europa 3.656
SA - Sud America 475
AF - Africa 119
OC - Oceania 38
Continente sconosciuto - Info sul continente non disponibili 2
Totale 12.581
Nazione #
US - Stati Uniti d'America 3.977
CN - Cina 1.223
SG - Singapore 1.076
IT - Italia 924
GB - Regno Unito 777
DE - Germania 609
HK - Hong Kong 458
VN - Vietnam 356
BR - Brasile 348
CA - Canada 268
RU - Federazione Russa 229
SE - Svezia 221
FR - Francia 196
IN - India 175
NL - Olanda 153
BD - Bangladesh 139
FI - Finlandia 103
JP - Giappone 102
TR - Turchia 99
KR - Corea 82
IE - Irlanda 78
ID - Indonesia 75
ES - Italia 73
DK - Danimarca 55
MX - Messico 55
CI - Costa d'Avorio 53
AR - Argentina 48
UA - Ucraina 36
BE - Belgio 35
CH - Svizzera 31
AT - Austria 30
AU - Australia 29
PH - Filippine 20
PK - Pakistan 20
CO - Colombia 19
PL - Polonia 19
CL - Cile 18
ZA - Sudafrica 18
IR - Iran 17
SA - Arabia Saudita 17
MA - Marocco 16
VE - Venezuela 16
UZ - Uzbekistan 15
IQ - Iraq 13
EC - Ecuador 12
GR - Grecia 12
NO - Norvegia 11
CZ - Repubblica Ceca 10
IL - Israele 10
DZ - Algeria 9
TW - Taiwan 9
EG - Egitto 8
NP - Nepal 8
NZ - Nuova Zelanda 8
AE - Emirati Arabi Uniti 7
HR - Croazia 7
PT - Portogallo 7
SI - Slovenia 7
KG - Kirghizistan 6
KZ - Kazakistan 6
MY - Malesia 6
PE - Perù 6
RO - Romania 6
GT - Guatemala 5
JM - Giamaica 5
LT - Lituania 5
NI - Nicaragua 5
TH - Thailandia 5
TT - Trinidad e Tobago 5
UY - Uruguay 5
CR - Costa Rica 4
ET - Etiopia 4
HU - Ungheria 4
RS - Serbia 4
HN - Honduras 3
PA - Panama 3
PY - Paraguay 3
SC - Seychelles 3
TN - Tunisia 3
AL - Albania 2
AM - Armenia 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
DO - Repubblica Dominicana 2
EU - Europa 2
KE - Kenya 2
LB - Libano 2
MD - Moldavia 2
MT - Malta 2
PS - Palestinian Territory 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BY - Bielorussia 1
CY - Cipro 1
EE - Estonia 1
GE - Georgia 1
JO - Giordania 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
Totale 12.575
Città #
Singapore 596
Southend 521
Ashburn 477
Hong Kong 381
Milan 380
San Jose 248
Dallas 239
Chandler 235
Beijing 208
Munich 180
Fairfield 160
Montréal 159
Seattle 141
Council Bluffs 137
Hefei 124
Wilmington 119
Mcallen 115
Frankfurt am Main 106
Los Angeles 101
Ho Chi Minh City 95
Hanoi 92
New York 91
Santa Clara 89
Ann Arbor 86
Dublin 78
Woodbridge 78
Princeton 72
Cambridge 71
Houston 68
Lauterbourg 63
Helsinki 62
Bengaluru 59
Jakarta 58
Guangzhou 57
Istanbul 56
Seoul 54
Abidjan 53
Dearborn 52
Tokyo 51
Buffalo 48
Moscow 46
Toronto 44
Phoenix 42
São Paulo 41
Nanjing 36
Rome 36
Shanghai 33
Boardman 32
Columbus 29
Des Moines 28
Nuremberg 27
Da Nang 25
Brussels 24
Jinan 24
Orem 23
Tianjin 23
The Dalles 22
Rio de Janeiro 21
Cangzhou 20
Vienna 20
Turin 19
Naples 18
Shenzhen 18
Wuhan 18
Amsterdam 17
Turku 17
Atlanta 16
Berlin 16
Haiphong 16
Hangzhou 16
Mountain View 16
San Diego 16
Shenyang 16
Bologna 15
Montreal 15
Paris 15
London 14
Silver Spring 14
Changsha 13
Chicago 13
Genoa 13
Stockholm 13
Washington 13
Redwood City 12
San Francisco 12
Zurich 12
Buenos Aires 11
Monza 11
Murcia 11
Reston 11
Ankara 10
Fremont 10
Medford 10
New Delhi 10
Ningbo 10
Tashkent 10
Bühl 9
Grafing 9
Johannesburg 9
Karachi 9
Totale 7.189
Nome #
Fostering inflammatory bowel disease: sphingolipid strategies to join forces 779
Biomarkers for acute and chronic graft versus host disease: state of the art 777
Single-cell profiling reveals the dynamics of cytomegalovirusspecific T-cells in haploidentical hematopoietic stem cell transplantation 429
Sphingosine Kinase 2 and Ceramide Transport as Key Targets of the Natural Flavonoid Luteolin to Induce Apoptosis in Colon Cancer Cells 344
What do we mean by long COVID? A scoping review of the cognitive sequelae of SARS-CoV-2 infection 323
Costimulatory Molecules and Immune Checkpoints Are Differentially Expressed on Different Subsets of Dendritic Cells 316
Luteolin induces an alteration of the Ceramide/Sphingosine-1-phosphate ratio leading to apoptosis in human colon cancer cells 288
Extracellular sphingosine-1-phosphate : a novel actor in human glioblastoma stem cell survival 274
A sphingosine-1-phosphate autocrine loop promotes proliferation and stemness of glioblastoma stem cells 248
Extracellular Vesicles After Allogeneic Hematopoietic Cell Transplantation: Emerging Role in Post-Transplant Complications 236
Pretransplant active disease status and HLA class II mismatching are associated with increased incidence and severity of cytokine release syndrome after haploidentical transplantation with posttransplant cyclophosphamide 233
The role and function of sphingolipids in glioblastoma multiforme 229
A sphingosine-1-phosphate autocrine loop protects glioblastoma stem cells against death 228
Role of "sphingolipid rheostat" in mediating the apoptotic effect of luteolin in colon cancer cells 227
Host immune responses in HIV-1 infection : The emerging pathogenic role of siglecs and their clinical correlates 223
Adipose mesenchymal stem cells and “regenerative adipose tissue graft” (lipogems™) for musculoskeletal regeneration 217
Hepatic natural killer cells: Organ-specific sentinels of liver immune homeostasis and physiopathology 217
Mesenchymal stem cells : potential for therapy and treatment of chronic non-healing skin wounds 216
Potential use of human adipose mesenchymal stromal cells for intervertebral disc regeneration : a preliminary study on biglycan-deficient murine model of chronic disc degeneration 215
A 40 colors spectral panel to decipher human NK cell involvement in the establishment of NeuroCOVID-19 214
Gene Expression Profile Analysis of Human Mesenchymal Stem Cells from Herniated and Degenerated Intervertebral Discs Reveals Different Expression of Osteopontin 209
The early expansion of anergic NKG2Apos/CD56dim/CD16negnatural killer represents a therapeutic target in haploidentical hematopoietic stem cell transplantation 206
Autocrine/paracrine sphingosine-1-phosphate fuels proliferative and stemness qualities of glioblastoma stem cells 200
Single-cell profiling identifies impaired adaptive NK cells expanded after HCMV reactivation in haploidentical HSCT 199
Extracellular sphingosine-1-phosphate contributes to survival properties of glioblastoma stem cells 197
Multi-layered deep immune profiling, SARS-CoV-2 RNAemia and inflammation in unvaccinated COVID-19 individuals with persistent symptoms 194
On the way to become a natural killer cell 193
Cancer Immunotherapy by Blocking Immune Checkpoints on Innate Lymphocytes 193
Platelet-derived sphingosine-1-phosphate and inflammation: from basic mechanisms to clinical implications 191
Platelets from glioblastoma patients promote angiogenesis of tumor endothelial cells and exhibit increased VEGF content and release 190
Autocrine sphingosine-1-phosphate fuels growth and stemness in glioblastoma stem cells 188
Innate Immune Responses in the Outcome of Haploidentical Hematopoietic Stem Cell Transplantation to Cure Hematologic Malignancies 187
Landscape of Immune Cell States and Ecosystems in Patients with Myelodysplastic Syndrome to Rene Prognostic Assessment and Predict Treatment Response 185
Emerging roles of bioactive sphingoids in glioblastoma aggressiveness 184
Selected memory T cells infused post haploidentical hematopoietic stem cell transplantation persist and hyper-expand 183
Transcriptomic profile of TNF high MAIT cells is linked to B cell response following SARS-CoV-2 vaccination 171
Development of Human ILCs and Impact of Unconventional Cytotoxic Subsets in the Pathophysiology of Inflammatory Diseases and Cancer 169
EXTRACELLULAR SPHINGOSINE-1-PHOSPHATE ACTS AS A SURVIVAL FACTOR FOR HUMAN GLIOBLASTOMA STEM CELLS 169
Immunophenotypic characterization of peripheral blood dendritic cell subsets in patients with myelodysplastic syndromes. 169
Expansion of memory Vδ2 T cells following SARS-CoV-2 vaccination revealed by temporal single-cell transcriptomics 168
Natural Killer cells in HIV-1 infection and therapy 164
Extracellular Vesicles as Biomarkers of Acute Graft-vs.-Host Disease After Haploidentical Stem Cell Transplantation and Post-Transplant Cyclophosphamide 163
Operationalisation of post-COVID condition case definition in a comprehensive research protocol 157
Expansion of memory Vδ2 T cells following repeated BNT162b2 mRNA-based vaccine revealed by temporal single-cell transcriptomics 156
Natural Killer Cells in SARS-CoV-2 Infection: Pathophysiology and Therapeutic Implications 153
HIV-1-induced inflammation shapes innate immunity and induces adaptive traits in NK cells 141
Targeting NKG2A to elucidate natural killer cell ontogenesis and to develop novel immune-therapeutic strategies in cancer therapy 140
NK cells to cure cancer 138
A 36-antigen spectral flow cytometry panel to unravel human NK cell differentiation and education 136
DECIPHERING THE ROLE OF IMMUNE SYSTEM DYSFUNCTION IN MYELODYSPLASTIC SYNDROMES CLASSIFICATION AND PROGNOSIS 133
Multi-methodologic dissection of human Natural Killer cell ontogenesis to study the contribution of unconventional NK cell subsets and other Innate Lymphoid Cells (ILCs) 123
Disrupted innate lymphoid cell development shapes prognosis and therapy outcomes in myelodysplastic syndrome patients 120
Deciphering the role of immune system dysfunction in patients with Myelodysplastic Syndrome to refine the prognostic assessment and predict treatment response 114
Unveiling the roles of unconventional subsets and other Innate Lymphoid Cells in Natural Killer cell ontogenesis: the development of an autologous Bone Marrow niche mimicking system 104
Characterization and Clinical Implications of p53 Dysfunction in Patients With Myelodysplastic Syndromes 103
Expansion of memory Vδ2 T cells following repeated BNT162b2 mRNA-based vaccine revealed by temporal single-cell transcriptomics 98
NKG2A blockade to unleash NK cells after haploidentical hematopoietic stem cell transplantation 97
The immunome profile of myelodysplastic syndrome patients defines different prognostic groups and shows a predictive potential to hypomethylating therapy 95
Relevance and heterogeneity of adaptive NK cells in the scenario of SARS-CoV-2: between vaccination and natural infection 93
Persistence of KIRneg NK cells after haploidentical hematopoietic stem cell transplantation protects from human cytomegalovirus infection/reactivation 92
Flow Cytometric Profiling of Leukocyte Responses to Nanocarrier-Delivered RyR2-Targeted siRNA 87
Phenotypic characterization of innate lymphoid cells in myelodysplastic syndromes: towards the comprehension of their role in disease etiology and prognosis 83
The twisted road to become a mature Natural Killer Cell: development of an autologous system mimicking the bone marrow niche to study their ontogenesis 81
Unveiling the roles of unconventional subsets and other Innate Lymphoid Cells in human Natural Killer cell ontogenesis 80
Unveiling ILC-poiesis disruption in myelodysplastic syndromes 78
The expansion of adaptive-like NK cells following BNT162b2 vaccination contributes to the vaccine-induced protection against SARS-CoV-2 infection 77
Spatiotemporal Atlas of Pro-Inflammatory (NF-κB) and Anti-Inflammatory (STAT6) Signalling Using Reporter Mice during mRNA Vaccination 54
PU.1-Activated Genomic Regions Define Low-risk MDS Subsets Characterized by Immune Dysregulation and Disease Progression 40
null 5
Totale 13.083
Categoria #
all - tutte 32.538
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.538


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021103 0 0 0 0 0 0 0 0 0 0 53 50
2021/2022717 55 51 58 36 50 31 29 45 105 97 40 120
2022/2023933 124 111 84 76 80 160 35 52 109 19 38 45
2023/2024954 40 85 49 88 228 82 63 64 45 31 75 104
2024/20252.071 67 155 49 174 114 83 89 184 215 209 211 521
2025/20265.402 509 479 509 544 480 319 752 208 477 393 732 0
Totale 13.083